209 related articles for article (PubMed ID: 21447739)
1. p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb.
Zeng Y; Kotake Y; Pei XH; Smith MD; Xiong Y
Cancer Res; 2011 Apr; 71(7):2781-92. PubMed ID: 21447739
[TBL] [Abstract][Full Text] [Related]
2. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
3. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
4. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
5. A novel zinc finger protein Zfp277 mediates transcriptional repression of the Ink4a/arf locus through polycomb repressive complex 1.
Negishi M; Saraya A; Mochizuki S; Helin K; Koseki H; Iwama A
PLoS One; 2010 Aug; 5(8):e12373. PubMed ID: 20808772
[TBL] [Abstract][Full Text] [Related]
6. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor.
Rocha S; Campbell KJ; Perkins ND
Mol Cell; 2003 Jul; 12(1):15-25. PubMed ID: 12887889
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.
Gonzalez S; Klatt P; Delgado S; Conde E; Lopez-Rios F; Sanchez-Cespedes M; Mendez J; Antequera F; Serrano M
Nature; 2006 Mar; 440(7084):702-6. PubMed ID: 16572177
[TBL] [Abstract][Full Text] [Related]
8. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
[TBL] [Abstract][Full Text] [Related]
9. p19ARF directly and differentially controls the functions of c-Myc independently of p53.
Qi Y; Gregory MA; Li Z; Brousal JP; West K; Hann SR
Nature; 2004 Oct; 431(7009):712-7. PubMed ID: 15361884
[TBL] [Abstract][Full Text] [Related]
10. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
Shamanin VA; Androphy EJ
Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
[TBL] [Abstract][Full Text] [Related]
11. Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3.
Miki J; Fujimura Y; Koseki H; Kamijo T
Genes Cells; 2007 Dec; 12(12):1371-82. PubMed ID: 18076574
[TBL] [Abstract][Full Text] [Related]
12. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
13. A new mechanism of inactivation of the INK4/ARF locus.
Gonzalez S; Serrano M
Cell Cycle; 2006 Jul; 5(13):1382-4. PubMed ID: 16855387
[TBL] [Abstract][Full Text] [Related]
14. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
15. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
[TBL] [Abstract][Full Text] [Related]
16. ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation.
Kobayashi T; Wang J; Al-Ahmadie H; Abate-Shen C
Mol Cancer Res; 2013 Aug; 11(8):828-33. PubMed ID: 23817020
[TBL] [Abstract][Full Text] [Related]
17. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
[TBL] [Abstract][Full Text] [Related]
18. RUVBL2 is a novel repressor of ARF transcription.
Xie C; Wang W; Yang F; Wu M; Mei Y
FEBS Lett; 2012 Feb; 586(4):435-41. PubMed ID: 22285491
[TBL] [Abstract][Full Text] [Related]
19. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression.
Aguilo F; Zhou MM; Walsh MJ
Cancer Res; 2011 Aug; 71(16):5365-9. PubMed ID: 21828241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
